Quantcast

Latest Medicine Stories

2014-09-16 08:30:35

Leading interoperability platform will accelerate Flagler's efforts to achieve greater connectivity across the community and create successful clinical integration network CHICAGO, Sept. 16, 2014 /PRNewswire/ -- Flagler Hospital, located in St. Augustine, Fla., has selected the Allscripts dbMotion(TM) solution to connect a myriad of electronic health records across the community. In creating a single, longitudinal patient record through Allscripts dbMotion, Flagler Hospital seeks to...

2014-09-16 08:30:33

Disaster Recovery Solution Provides Answers to Cost and Time Challenges BOSTON and HERZLIYA, Israel, September 16, 2014 /PRNewswire/ -- Healthcare organizations rely on business continuity and disaster recovery (BC/DR) plans to ensure their IT functions remain operational in case of data loss from a man-made or natural disaster. The applications and data at these organizations are often comprised of important medical research and confidential patient records, which means...

2014-09-16 08:30:30

"PIM" Designation For DCVax-L Is First Step In 2-Step Process for Early Access Approval BETHESDA, Md., Sept. 16, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, announced today that its DCVax-L is the first product to receive formal designation as a "Promising Innovative Medicine" (PIM) under the new "Early Access to Medicines Scheme" (EAMS) launched in the UK...

2014-09-16 08:30:17

Innovative needle design to enhance patient safety LAWRENCE, Mass., Sept. 16, 2014 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced its single needle technology, OneSite(TM), has received FDA clearance. http://photos.prnewswire.com/prnvar/20110503/MM94799LOGO The OneSite employs a unique dual lumen needle design offered in both a sharp version with MasterGuard® and a buttonhole version with SteriPick®...

2014-09-16 08:30:15

Funding to Support Development of New Treatments for Drug-Resistant Gram-Negative Bacterial Infections OKLAHOMA CITY, Sept. 16, 2014 /PRNewswire/ -- Synereca Pharmaceutics, Inc. (SPI), a research-stage biopharmaceutical company developing novel orally active drugs that restore or increase the effectiveness of existing antibiotics, announced today a $1.4 million convertible debt financing. Accele Venture Partners, the investing arm of life sciences accelerator Accele Biopharma, Inc.,...

2014-09-16 08:30:11

New initiative designed to protect children from insect-borne disease MILFORD, Mass., Sept. 16, 2014 /PRNewswire/ -- SeraCare Life Sciences, a provider of high-quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, today announced the Nets for Kids initiative. For every purchase over $100 of insect-borne disease products, SeraCare will donate a mosquito net to a child in a developing country. "Insect-borne...

2014-09-16 08:30:07

ACCU-CHEK Aviva Expert offers people with diabetes a new and easy way to simplify complex calculations to deliver precise insulin dosing advice INDIANAPOLIS, Sept. 16, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that Roche's ACCU-CHEK(®) Aviva Expert system, the first and only blood glucose meter system with a built-in insulin calculator to be approved by the U.S. Food and Drug Administration (FDA), is now available by prescription. The device represents...

2014-09-16 08:29:53

-- Differentiated Design Yields Excellent Tissue Healing and Sustained Safety Profile -- DURHAM, N.C., Sept. 16, 2014 /PRNewswire/ -- Micell Technologies, Inc. today announced that three-year clinical results from the DESSOLVE I and DESSOLVE II trials of its MiStent Sirolimus Eluting Absorbable Polymer Coronary Stent System (MiStent SES(®)) were presented at the 26th Annual Transcatheter Cardiovascular Therapeutics (TCT) Conference being held in Washington, D.C., September 13-17....

2014-09-16 08:29:49

Expanded Collaboration Supports Phase 2 Clinical Trial Initiation of First-In-Class ENaC Inhibitor for the Treatment of Cystic Fibrosis DURHAM, N.C., Sept. 16, 2014 /PRNewswire-USNewswire/ -- Parion Sciences today announced it has received a $3 million award from Cystic Fibrosis Foundation Therapeutics (CFFT) to support the development of P-1037, Parion's new investigational treatment for cystic fibrosis (CF). This award will accelerate the initiation of a phase 2 trial for P-1037...

2014-09-16 08:29:41

Clinical Trials Mark Important Milestone in Development of Two Highly Complex Products PITTSBURGH, Sept. 16, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL), one of the world's leading global pharmaceutical companies, today announced it is initiating Phase III clinical trials for its generic version of GlaxoSmithKline's Advair Diskus® and its insulin analog to Sanofi's Lantus®. http://photos.prnewswire.com/prnvar/20140423/77793 In October 2014, Mylan will commence a Phase III...


Latest Medicine Reference Libraries

Pharmacophobia
2013-12-24 12:55:45

Pharmacophobia or medication phobia, comes from Greek pharmakon, meaning “drug, medicine” and phobos, meaning “fear”, is the fear of the use of pharmacological treatments. In severe, excessive, and irrational cases, it might be a type of specific phobia. While lack of awareness by patient of adverse drug reactions can have a serious consequence, having a phobia of medications can also have serious detrimental effects on the patient’s health. Medication phobia can also lead to...

Pork Tapeworm, Taenia solium
2014-01-12 00:00:00

The pork tapeworm (Taenia solium), also known simply as a tapeworm, is a species of parasitic worm that is classified within the Platyhelminthes phylum. This species infects pigs and humans in many areas of the world including Africa, Southern Europe, Asia, South America, and some areas of North America. This species can cause cysticercosis in its larval stage, which is one of the major causes of seizures in humans. The pork tapeworm can reach an average body length between 2 to 3 meters, but...

Rodent Tapeworm. Hymenolepis microstoma
2014-01-12 00:00:00

The rodent tapeworm (Hymenolepis microstoma) is a parasitic worm that is classified within the Platyhelminthes phylum. This species affects rodents across the world, causing hymenolepiasis, but it does not often affect humans. Most of the available information regarding tapeworms is derived from the studies conducted on this worm and the other members of its genus, Hymenolepis. These worms have been present in laboratories since the 1950's and can either be raised and kept in a culture or be...

Paragonimus westermani
2014-01-12 00:00:00

Paragonimus westermani is a species of fluke, or flatworm that is classified within the Platyhelminthes phylum. This species is abundant in South America and Asia and affects the lungs of humans and other hosts. It was first discovered in 1878 in Europe after two Bengal tigers died. In 1879, Ringer found this species in the lungs of a human. Manson and Erwin von Baelz identified the sputum and eggs separately in 1880, after which Manson asserted that a snail was most likely the worm's...

Echocardiogram
2013-07-29 11:11:00

An echocardiogram is a test that, much like an ultrasound, uses sound waves to create a moving image of the heart. The most common type of echocardiogram is performed transthoracic, meaning the image is taken through a probe against the chest. A TTE does not involve radiation and is a very safe procedure. A cardiac sonographer will put a gel on the patient's chest and move the transducer around different areas, including directly anterior to the breastbone, inferior and lateral to the right...

More Articles (170 articles) »
Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'